Trials / Recruiting
RecruitingNCT06262594
Lemborexant Treatment of Insomnia Linked to Epilepsy
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- University of Manitoba · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this clinical trial is to assess whether Lemborexant can improve sleep in patients with epilepsy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Lemborexant | Drug is administered |
| DRUG | Placebo | Drug is administered |
Timeline
- Start date
- 2024-10-29
- Primary completion
- 2026-04-18
- Completion
- 2027-04-18
- First posted
- 2024-02-16
- Last updated
- 2025-02-13
Locations
2 sites across 2 countries: United States, Canada
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06262594. Inclusion in this directory is not an endorsement.